We did not detect differences in NKG2D expression, neither on FcεRIγ− adaptive nor on FcεRIγ+ conventional NK cells from HCC patients, compared to control groups (Figure 4A). The gene discussed is KLRK1; the disease is hepatocellular carcinoma.